Literature DB >> 6971184

The control of leishmaniases.

C J Marinkelle.   

Abstract

Human leishmaniases are caused by at least 13 different species and subspecies of parasite of the genus Leishmania. These parasites are transmitted to man from other infected persons or mammals by sandflies when taking a blood meal. Leishmaniases have been reported from about 80 countries and probably some 400 000 new cases occur each year. Clinically the leishmaniases can be divided into three major groups: visceral leishmaniases, which are usually fatal if untreated; cutaneous leishmaniases, which often produce permanent facial disfigurement; and mucocutaneous leishmaniasis of the New World, which produces severe mutilation by destruction of the naso-oro-pharyngeal cavity and sometimes death. Since the various forms of leishmaniasis differ substantially from each other in their epidemiology, the strategy for control must be adapted to the local situation in each endemic area, after thorough ecological and epidemiological studies of the vectors, the hosts, and the landscape. If insufficient baseline information is available, failure of haphazardly applied control measures can be expected. Peridomestic insecticide spraying together with treatment of patients is effective in certain foci of anthroponotic cutaneous leishmaniasis, urban visceral leishmaniasis, and uta. Extensive programmes to eradicate desert rodents, combined with land reclamation, resulted in a considerable decrease in the incidence of zoonotic cutaneous leishmaniasis in vast areas of the USSR. Since control of zoonotic cutaneous/mucocutaneous leishmaniasis of the New World is hardly feasible at present, the only rational approach to prevent some of mucosal lesions is early diagnosis and radical treatment of patients with the rather unsatisfactory drugs at present available.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6971184      PMCID: PMC2396010     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis.

Authors:  A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1970       Impact factor: 2.184

2.  Epidemiological patterns of cutaneous leishmaniasis in Panama. II. Incidental occurrence of cases in non-endemic settlements.

Authors:  A Herrer; H A Christensen; R J Beumer
Journal:  Ann Trop Med Parasitol       Date:  1976-03

Review 3.  Epidemiology and ecology of leishmaniasis in Latin-America.

Authors:  R Lainson; J J Shaw
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

  3 in total
  8 in total

Review 1.  Biochemistry of the Leishmania species.

Authors:  R H Glew; A K Saha; S Das; A T Remaley
Journal:  Microbiol Rev       Date:  1988-12

2.  Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia.

Authors:  J P Dedet; R Melogno; F Cardenas; L Valda; C David; V Fernandez; M E Torrez; L Dimier-David; P Lyevre; M E Villareal
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

3.  The six diseases of WHO. Leishmaniasis.

Authors:  M L Chance
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-07

4.  Sporadic case of visceral leishmaniasis in sikkim, India.

Authors:  Luna Adhikari; T S K Singh; Dechenla Tsering; O P Dhakal; Amlan Gupta
Journal:  J Glob Infect Dis       Date:  2010-05

5.  Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar).

Authors:  Viroj Wiwanitkit
Journal:  Ther Clin Risk Manag       Date:  2012-06-22       Impact factor: 2.423

6.  Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia.

Authors:  Rezika Mohammed; Helina Fikre; Angela Schuster; Tigist Mekonnen; Johan van Griensven; Ermias Diro
Journal:  Curr Ther Res Clin Exp       Date:  2020-04-08

7.  Incidence of Mortality and Its Predictors Among Adult Visceral Leishmaniasis Patients at the University of Gondar Hospital: A Retrospective Cohort Study.

Authors:  Yigizie Yeshaw; Adino Tesfahun Tsegaye; Solomon Gedlu Nigatu
Journal:  Infect Drug Resist       Date:  2020-03-24       Impact factor: 4.003

8.  Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.

Authors:  Yasmin Silva Rizk; Sandy Santos-Pereira; Luiza Gervazoni; Daiana de Jesus Hardoim; Flávia de Oliveira Cardoso; Celeste da Silva Freitas de Souza; Marcelo Pelajo-Machado; Carlos Alexandre Carollo; Carla Cardozo Pinto de Arruda; Elmo Eduardo Almeida-Amaral; Tânia Zaverucha-do-Valle; Kátia da Silva Calabrese
Journal:  Front Cell Infect Microbiol       Date:  2021-02-25       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.